Reach Us 44-7452-259145

Abstract

3. Biogenerics-need for Regulatory development in India

First-generation biopharmaceuticals have come off patent or lose marketing exclusivity. This has paved the way for the manufacture of generic biopharmaceuticals which are otherwise called as biogenerics. According to estimation, biologic drugs worth more than $80 billion in global sales will lose patent protection by the year 2015, presenting a major opportunity for biogenerics. Biologic-based drugs are expected to push the contract manufacturing industry for growth and development over the next few years. Already India is enjoying a significant growth in the biogenerics manufacturing sector. But some of the significant obstacles with respect to regulations and their compliance with other countries must be considered. The main aim of the article is to demonstrate an immediate need for regulatory development of biogenerics in India. Since the market size for biogenerics is highly appreciable and has breaked the barriers of historically restricted usage due to highly costly biologicals. They are becoming technologically feasible and financially necessary, therefore are gaining regulatory and political attention. Indian companies can establish expertise in biogenerics, which can then be transferred to more established pharmaceutical markets. Hence in order to make India as a leading contributor for biogenerics, a clear regulatory pathway is required to meet foreign standards. This will sufficiently provide an opportunity to India to compete with countries like America and Europe in terms of regulatory aspects of biogenerics.


Author(s): Palleti Lakshmi Prathusha N. Vishal Gupta

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Recommended Conferences
Google scholar citation report
Citations : 7538

International Journal of Drug Development and Research received 7538 citations as per google scholar report

International Journal of Drug Development and Research peer review process verified at publons
Abstracted/Indexed in
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • MIAR
  • ResearchGate
  • University Grants Commission
  • Secret Search Engine Labs
  • Euro Pub

View More »

Flyer image

tempobet

tempobet giriş

tempobet giriş

tipobet süpertotobet yeni adres süperbahis 747 güvenilir bahis siteleri telefonda sex sohbet
https://wowcappadocia.com
https://cappadocia-hotels.com
https://balloon-rides.net

https://paperio-live.com

rolex replica

https://agario.red

https://naughtyworms.com

Vaporesso
Smok
https://www.unitedluxury.net/